Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Genia Long
Observed name:
Long, Genia
Institution:
Analysis Group (United States)
Observed institutions:
National Bureau of Economic Research,
Harvard University,
Duke University,
Analysis Group (United States)
OpenAlex ID:
A5103853167
The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation
2007
·
David M. Cutler
, Genia Long
, et al.
·
Health Affairs
·
151
The Roles Of Patents And Research And Development Incentives In Biopharmaceutical Innovation
2015
·
Henry G. Grabowski
, Joseph A. DiMasi
, et al.
·
Health Affairs
·
92
The Market For Follow-On Biologics: How Will It Evolve?
2006
·
Henry Grabowski
, Iain Cockburn
, et al.
·
Health Affairs
·
91
Recent trends in brand-name and generic drug competition
2013
·
Henry Grabowski
, Genia Long
, et al.
·
Journal of Medical Economics
·
83
The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals
2015
·
Iain Cockburn
, Genia Long
·
Expert Opinion on Therapeutic Patents
·
70
PDF
Updated trends in US brand-name and generic drug competition
2016
·
Henry Grabowski
, Genia Long
, et al.
·
Journal of Medical Economics
·
68
PDF
Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act
2011
·
Henry G. Grabowski
, Margaret Kyle
, et al.
·
Health Affairs
·
57
Financing Drug Innovation in the US: Current Framework and Emerging Challenges
2020
·
David Cutler
, Noam Kirson
, et al.
·
PharmacoEconomics
·
35
PDF
Continuing trends in U.S. brand-name and generic drug competition
2021
·
Henry Grabowski
, Genia Long
, et al.
·
Journal of Medical Economics
·
33
Implementation of the biosimilar pathway: economic and policy issues.
2011
·
Henry Grabowski
, Genia Long
, et al.
·
PubMed
·
31
Data exclusivity for biologics
2010
·
Henry Grabowski
, Genia Long
, et al.
·
Nature Reviews Drug Discovery
·
25
Insurance switching and mismatch between the costs and benefits of new technologies.
2017
·
David Cutler
, Michael Ciarametaro
, et al.
·
PubMed
·
17
Evolving provider payment models and patient access to innovative medical technology
2014
·
Genia Long
, Richard Mortimer
, et al.
·
Journal of Medical Economics
·
11
PDF
Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act
2024
·
Henry Grabowski
, Joseph A. DiMasi
, et al.
·
Health Affairs
·
10
Pharmaceutical Spending and Health Outcomes
2007
·
Pierre-Yves Cremieux
, Denise Jarvinen
, et al.
·
Cambridge University Press eBooks
·
10
Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act
2024
·
Henry Grabowski
, Genia Long
·
Journal of Medical Economics
·
9
PDF
The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
2006
·
Genia Long
, David Cutler
, et al.
·
National Bureau of Economic Research
·
9
PDF
Federal government-interest patent disclosures for recent top-selling drugs
2019
·
Genia Long
·
Journal of Medical Economics
·
8
Antihypertensive drugs: a perspective on the value of improved blood pressure control in the USA
2007
·
Genia Long
, David M. Cutler
, et al.
·
European Heart Journal Supplements
·
6
Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies
2013
·
Anna Kaltenboeck
, Genia Long
, et al.
·
Expert Review of Clinical Pharmacology
·
5
The Impact of the Inflation Reduction Act’s Drug Price Negotiation Program on Incentives for Clinical Development of New Drugs
2025
·
Robert J. Nordyke
, Julie A. Patterson
, et al.
·
Value in Health
·
2
PDF
Challenges in Developing and Assessing Comparative Effectiveness Evidence for Medical Technology
2017
·
Richard Price
, Genia Long
·
Springer eBooks
·
1
Commercial Importation of Prescription Drugs in the United States: Short-Run Implications
2011
·
Patricia M. Danzon
, Scott J. Johnson
, et al.
·
Journal of Health Politics Policy and Law
·
1
Trends in industry-sponsored clinical trial activity since passage of the Inflation Reduction Act
2026
·
Long, Genia
·
Figshare
Trends in industry-sponsored clinical trial activity since passage of the Inflation Reduction Act
2026
·
Genia Long
·
Journal of Medical Economics
PDF
Show more works
View as search
Works count:
31
Citation count:
825
H-index:
12
I10-index:
15
Year
Topic
Type